As of 10 January 2023, 84,471 confirmed cases of mpox and 285 deaths were reported from 110 countries/territories globally. The countries reporting the majority of cases are mainly in Europe and the Americas.
Africa update (endemic and non-endemic countries)
Since the beginning of 2022, the continent has reported 1,267 confirmed cases and 226 deaths (CFR: 17.8%) of mpox from eight endemic Africa Union (AU) Member States (MS): Benin (3 confirmed cases; 0 confirmed deaths), Cameroon (18; 3), Central African Republic (CAR) (13; 3), Congo (5; 3), Democratic Republic of Congo (DRC) (319; 204), Ghana (116; 4), Liberia (6; 0), Nigeria (756; 7) and five non-endemic MS: Egypt (4; 0), Morocco (3; 0), Mozambique (1; 1), South Africa (5; 0) and Sudan (18; 1).
Five MS have not reported mpox cases in the last three months: Benin, Congo, Morocco, Sierra Leone and South Africa. This week, five new confirmed cases and no new deaths of mpox were reported from Liberia (2 cases; 0 deaths) and Nigeria (3; 0).
Liberia
Since the last update (4 November 2022), the MoH reported two new confirmed cases and no new deaths of mpox. There is a 100% increase in the number of new confirmed cases reported compared to the last update. Cumulatively, six confirmed cases and no deaths of mpox were reported from four counties: Grand Bassa, Montserrado, Maryland and Bomi.
Nigeria
Since the last update (23 December 2022), the Nigeria Center for Disease Control (NCDC) reported three new confirmed cases and no new deaths of mpox. This is a 94% decrease in the number of new confirmed cases reported compared to the last update. Cumulatively, 756 confirmed cases and seven deaths (CFR: 1%) of mpox were reported from 36 states and the federal capital.